Periodic Reporting for period 4 - TIL-FIT (Increasing the fitness of tumor-infiltrating T cells for cellular immunotherapy)

Adoptive T cell therapies (ACTs) are emerging as a promising strategy to treat cancer. Tumor-infiltrating lymphocytes (TILs) are expanded ex vivo, selected for recognition of neoantigens, further expanded and then infused back into patients. This procedure requires extensive...